Megan Prochaska, MD MPH FASN is a nephrologist who cares for all patients with kidney related conditions but specializes in kidney stone prevention. She is a Fellow of the American Society of Nephrology and a member of the Research on Calculus Kinetics (ROCK) Society. Her research focuses in multiple different areas of kidney stones, including human based studies to determine mechanisms of kidney stone formation and identify new prevention strategies.
Delaying Progression of Chronic Kidney Disease.
Delaying Progression of Chronic Kidney Disease. JAMA. 2025 Aug 19; 334(7):629-630.
PMID: 40668565
Mitigating heart failure risk in patients with diabetes and chronic kidney disease.
Mitigating heart failure risk in patients with diabetes and chronic kidney disease. Curr Opin Cardiol. 2025 May 01; 40(3):178-183.
PMID: 39998480
Nephrolithiasis.
Nephrolithiasis. Adv Kidney Dis Health. 2024 11; 31(6):529-537.
PMID: 39577887
Insulin Resistance in Hypercalciuric Calcium Kidney Stone Patients.
Insulin Resistance in Hypercalciuric Calcium Kidney Stone Patients. Kidney Med. 2024 Dec; 6(12):100922.
PMID: 39634328
Chronic Fructose and Sucrose Intake and 24-Hour Urine Composition.
Chronic Fructose and Sucrose Intake and 24-Hour Urine Composition. Kidney360. 2024 08 01; 5(8):1167-1177.
PMID: 39012708
Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers.
Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers. Kidney360. 2024 02 01; 5(2):228-236.
PMID: 38251931
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls.
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816.
PMID: 37823200
Metabolomic profiles and pathogenesis of nephrolithiasis.
Metabolomic profiles and pathogenesis of nephrolithiasis. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):490-495.
PMID: 37530089
Clinical Effectiveness of Calcium Oxalate Stone Treatments.
Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
PMID: 36412567
What treatments reduce kidney stone risk in patients with bowel disease?
What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
PMID: 35976425